SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-14-000103
Filing Date
2014-01-29
Accepted
2014-01-29 20:01:09
Documents
1
Period of Report
2014-01-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 5284
  Complete submission text file 0000904454-14-000103.txt   6906
Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542 609-683-5656
DP VIII Associates, L.P. (Reporting) CIK: 0001465143 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-36281 | Film No.: 14558360